How to Dissolve Adhesions Without Surgery

Detailed guide to non-surgical methods for softening and reducing internal adhesions. Use targeted physical therapy and systemic enzyme support.

No pill or therapy reliably dissolves mature adhesions the way a surgeon’s blade or laser can, but a growing number of non-surgical strategies can reduce adhesion-related symptoms, soften fibrotic tissue, and in some cases appear to break down adhesion bands. The approaches range from hands-on manual therapy and ultrasound to enzymatic supplements and experimental drug injections, each backed by different levels of evidence. Understanding what adhesions actually are, which methods have real data behind them, and which remain speculative will help you make better decisions with your doctor about whether surgery is truly necessary.

Why Adhesions Form in the First Place

Adhesions are bands of scar-like tissue that connect surfaces inside the body that are not supposed to be connected. They most commonly follow abdominal or pelvic surgery, but can also result from infections, endometriosis, radiation, or trauma. The process begins when tissue injury triggers inflammation and disrupts the delicate lining of the peritoneum or joint capsule. The body lays down a temporary fibrin scaffold to patch the damage, much like the mesh of a scab on your skin. Normally, enzymes dissolve that scaffold within a few days and healing proceeds cleanly.

When that cleanup system fails, the trouble starts. Inflammatory signals, reduced blood flow to the injured area, and suppressed fibrin-dissolving activity allow the temporary scaffold to persist. Fibroblasts migrate into it, deposit collagen, and the structure matures into a tough, permanent adhesion band. Recent research points to damage to the peritoneal surface cells as the initial trigger, setting off a cascade of coagulation, inflammation, and collagen deposition that can start within hours of surgery. Once an adhesion fully matures with dense collagen cross-linking, it becomes much harder to reverse, which is why most non-surgical strategies work best when started relatively early or target the symptoms rather than the scar tissue itself.

Manual Therapy and Soft Tissue Mobilization

The non-surgical approach with the most clinical attention is manual physical therapy, where a trained therapist applies sustained pressure, stretching, and mobilization techniques directly to areas affected by adhesions. The idea is that carefully directed mechanical force can break apart or remodel the fibrous bands. A systematic review found preliminary strong evidence that soft tissue mobilization helps with symptoms of acute post-surgical adhesions and moderate evidence for chronic adhesion-related problems like small bowel obstructions and fertility issues.

A more recent systematic review reached a similar conclusion, finding that manual therapy holds potential as a non-invasive treatment for managing post-surgical adhesion symptoms, gastrointestinal disorders, and musculoskeletal problems related to adhesions. Case reports have documented patients with partial small bowel obstructions caused by adhesions who experienced resolution of their symptoms after focused manual soft tissue therapy, with results that held over time.

Animal research adds a biological mechanism to the clinical observations. In a rat model, a manual therapy protocol significantly reduced the area of primary adhesions after abdominal surgery. While all untreated rats developed adhesions at the surgical site, only about 40 percent of treated rats did. The effect was most pronounced when treatment started within the first week after surgery, which fits with what we know about the timeline of adhesion maturation.

The practical takeaway here is encouraging but comes with caveats. Manual therapy requires a skilled practitioner experienced in visceral or myofascial techniques. Results vary depending on adhesion location, maturity, and severity. And most of the published evidence consists of case reports, small trials, and systematic reviews of low-to-moderate quality studies. Still, for someone dealing with adhesion pain or restricted movement who wants to avoid reoperation, a course of manual therapy with a specialized physical therapist is one of the more credible options to explore.

Therapeutic Ultrasound

Therapeutic ultrasound, the kind used in physical therapy clinics rather than for imaging, sends sound waves into tissue to produce gentle heating and mechanical vibration. This can increase the extensibility of scar tissue and fibrotic structures, reduce pain, and improve range of motion in affected areas. The thermal effect softens collagen fibers, making the tissue more pliable and easier to stretch during rehabilitation exercises or manual therapy sessions.

Laboratory research has shown that ultrasound can influence fibrosis at the cellular level. In an in vitro study, ultrasound treatment significantly reduced collagen production by fibroblasts and altered the structure of the extracellular matrix they produced, creating a more complex and less dense fiber network compared to untreated controls. Whether those cellular changes translate directly to dissolving established internal adhesions in a living person remains an open question, but the biological plausibility is there.

Therapeutic ultrasound is most commonly used for superficial adhesions, joint capsule restrictions, and scar tissue near the body surface. Deep abdominal or pelvic adhesions are harder to reach effectively, and there is less clinical evidence for ultrasound in those locations. Many physical therapists combine ultrasound with manual therapy, using the ultrasound to warm and soften tissue before applying hands-on mobilization techniques.

Extracorporeal Shock Wave Therapy

Extracorporeal shock wave therapy (ESWT) sends focused pressure waves through the skin into deeper tissues. Originally developed for breaking up kidney stones, it has found a second life in treating musculoskeletal conditions and fibrotic tissue. The mechanism appears to involve reducing the activity of key fibrosis-promoting molecules and decreasing the density of fibroblasts in scar tissue.

In a study of patients with retracting scars on their hands, ESWT produced measurable changes in tissue composition, including increases in the type of collagen associated with healthy remodeling and improved blood vessel formation. Animal studies of spinal epidural fibrosis, the scar tissue that forms after back surgery, have shown that shock wave therapy can reduce fibrosis development. The evidence here is still early-stage, and ESWT is not widely offered for internal adhesions. But for adhesion-related fibrosis in accessible areas, particularly after orthopedic surgery or in superficial scar tissue, the data is becoming more interesting.

Enzymatic and Supplement-Based Approaches

Walk into a health food store asking about adhesions and you will likely hear about proteolytic enzymes, particularly serratiopeptidase (also called serrapeptase). This enzyme, originally isolated from silkworm gut bacteria, breaks down proteins including fibrin. It has documented anti-inflammatory properties, can thin inflammatory fluids, and has fibrinolytic activity, meaning it breaks down fibrin clots and deposits. The enzyme also breaks down dead tissue without harming living tissue, at least in the wound-healing context where it has been studied most.

The gap between serratiopeptidase’s biological activity and proof that it dissolves internal adhesions in humans is significant. Most of the published research on this enzyme focuses on reducing post-surgical swelling, improving antibiotic delivery through biofilms, and supporting wound healing. People taking serratiopeptidase for adhesions are essentially extrapolating from its known fibrinolytic and anti-inflammatory properties, which is reasonable as a hypothesis but not the same as clinical evidence. If you decide to try it, be aware that quality varies widely between supplement brands, and it should be taken on an empty stomach so it enters the bloodstream rather than just digesting food proteins in your gut.

A more targeted enzymatic approach involves collagenase, an enzyme that specifically breaks down collagen, the main structural protein in mature adhesions. Researchers have tested injecting collagenase directly into the abdominal cavity to dissolve peritoneal adhesions. In an animal study, collagenase dispersed the collagen fibers in adhesion bands while leaving the outer wall of abdominal organs intact. The force needed to separate adhered tissues was significantly lower in the collagenase-treated group compared to placebo. This “chemical scalpel” concept is promising but still experimental, and the obvious concern is ensuring the enzyme targets adhesion collagen without weakening healthy tissue structures nearby.

Experimental Drug Therapies on the Horizon

Several drug candidates are being studied for their ability to prevent or reduce adhesions by targeting the inflammatory and fibrotic pathways that drive adhesion formation. None of these are available as adhesion treatments for patients right now, but they represent where the field is heading.

Ghrelin, a hormone best known for regulating appetite, has shown the ability to significantly reduce post-surgical adhesions in animal models by blocking the TGF-β signaling pathway, one of the central drivers of fibrosis. It suppressed inflammatory gene expression and boosted the activity of proteins that inhibit scar-tissue formation. Telmisartan, a blood pressure medication, prevented fibrotic adhesion band formation in animal studies by reducing excessive collagen deposition and suppressing fibrosis-promoting genes. And quercetin, a plant flavonoid found in onions and berries, alleviated peritoneal adhesions in animal experiments by blocking the same TGF-β pathway through a different mechanism, inhibiting the transformation of peritoneal surface cells into scar-producing cells.

The common thread is that these agents all target inflammation and fibrosis at their molecular roots, typically the TGF-β signaling system. The challenge is translating animal results to humans, determining safe doses and delivery methods, and figuring out whether these drugs can reverse existing adhesions or only prevent new ones from forming around the time of surgery. For now, they remain laboratory findings with potential but no clinical availability.

Pentoxifylline and Vitamin E for Radiation-Induced Fibrosis

Radiation therapy can cause its own form of adhesion-like fibrosis, where tissues become dense, contracted, and stuck together. The combination of pentoxifylline (a drug that improves blood flow) and tocopherol (vitamin E) has been studied specifically for this problem. Both agents have a long history of use against radiation-induced fibrosis.

In a randomized, placebo-controlled trial, the combination produced meaningful regression of superficial radiation-induced fibrosis compared to placebo, with the treated group averaging about 60 percent surface regression versus about 43 percent in the placebo group. This is one of the few non-surgical interventions that has shown fibrosis regression in a controlled human trial, though it applies specifically to radiation fibrosis rather than post-surgical peritoneal adhesions. If your adhesion-like symptoms stem from radiation treatment, this combination is worth discussing with your oncologist.

Managing Abdominal Adhesions Without an Operation

For abdominal adhesions, especially those causing partial small bowel obstructions, non-operative management is now a standard first-line approach in many cases. When there are no signs of strangulation, peritonitis, or severe intestinal damage, evidence supports conservative management. This typically involves bowel rest (nothing by mouth), intravenous fluids, a nasogastric tube to decompress the stomach, and careful monitoring.

Water-soluble contrast media, given by mouth or through a nasogastric tube, play a dual role. Diagnostically, they help determine whether the obstruction will resolve on its own by tracking whether the contrast reaches the colon within a set time frame. Therapeutically, the hyperosmotic fluid draws water into the bowel lumen, which can help push contents past the point of partial obstruction. This approach does not dissolve the adhesion itself, but it can resolve the acute episode and buy time. Many patients with adhesive small bowel obstructions are managed successfully this way and avoid surgery altogether, though recurrence is common.

Minimally Invasive Procedures That Are Not Traditional Surgery

Some approaches sit in a gray zone between “non-surgical” and “surgical.” Epiduroscopy-guided adhesiolysis, for example, uses a tiny camera threaded into the epidural space of the spine to identify and break apart adhesions causing chronic back or leg pain. In patients with chronic sciatica, this procedure followed by targeted injection of steroids and local anesthetic reduced pain and functional disability and improved nerve function. It requires only a small needle puncture rather than an open incision.

For frozen shoulder, where adhesions form inside the joint capsule, hydrodilatation involves injecting fluid under pressure to stretch and tear the adhesions from within. A randomized trial compared hydrodilatation to arthroscopic capsular release (a more invasive surgical procedure) and found that while the surgical group had somewhat better shoulder scores, both groups improved significantly from baseline. For patients who prefer to avoid general anesthesia and an operating room, hydrodilatation offers a meaningful alternative that can be done in a clinic setting.

How to Know If You Have Adhesions

One of the frustrations of dealing with adhesions is that they are notoriously difficult to see on standard imaging. A systematic review of non-invasive imaging methods found that ultrasound and MRI performed reasonably well, with overall accuracy between about 76 and 100 percent for ultrasound and 79 to 90 percent for MRI, while CT scans lagged behind at around 66 percent. The wide range reflects differences in technique, operator skill, and what type of adhesion is being looked for.

A specialized technique called cine MRI, which takes rapid sequential images to watch how organs move during breathing, can detect adhesions by identifying areas where tissues that should slide freely against each other are stuck. One study found cine MRI had a sensitivity of about 88 percent and specificity of about 93 percent for abdominal adhesions, with particular accuracy for adhesions to the abdominal wall. A comparative study found that both abdominal ultrasound and cine MRI performed well for detecting adhesions to the abdominal wall, but cine MRI was superior for adhesions between internal organs. If you suspect adhesions are causing your symptoms, asking for a cine MRI rather than a standard CT scan gives your doctor a much better chance of actually seeing them.

Preventing Adhesions From Forming

The most effective non-surgical strategy for adhesions is preventing them during the initial surgery. Barrier materials placed between tissue surfaces during an operation can physically separate healing tissues so adhesions cannot form between them. A systematic review identified several barrier agents, including bioresorbable membranes and icodextrin solution, that significantly reduce adhesion incidence and severity after high-risk surgeries.

Surgical technique matters as much as any barrier product. Laparoscopic surgery, compared to open surgery, consistently produces fewer adhesions and fewer adhesion-related hospital readmissions. One large analysis found that adhesion-related readmissions dropped from about 4.3 percent with open surgery to about 1.7 percent with a laparoscopic approach. If you are facing an abdominal or pelvic operation, asking your surgeon about a laparoscopic approach and adhesion barrier products is one of the most impactful steps you can take. Prevention is far more reliable than any after-the-fact treatment.

What a Realistic Non-Surgical Plan Looks Like

If you are living with adhesion-related pain, restricted movement, or recurrent bowel problems and want to avoid surgery, the honest picture is that no single non-surgical method has strong enough evidence to guarantee results. But a reasonable plan might combine several approaches. Start with a qualified physical therapist experienced in visceral or myofascial mobilization for manual therapy, potentially augmented with therapeutic ultrasound. If symptoms involve a joint capsule, consider hydrodilatation. For acute bowel obstruction episodes, work with your gastroenterologist on conservative management with contrast studies to determine whether each episode will resolve on its own.

Enzymatic supplements like serratiopeptidase are biologically plausible but clinically unproven for this specific use, so treat them as a low-risk experiment rather than a reliable treatment. The experimental drug targets and collagenase injections are years away from clinical use at best. And if your fibrosis is radiation-related, pentoxifylline plus vitamin E has real clinical trial data behind it. Throughout all of this, getting proper imaging to confirm that adhesions are actually causing your symptoms is an underrated first step. Many people assume adhesions are to blame for chronic abdominal or pelvic pain when the cause lies elsewhere, and a cine MRI can help sort that out before you commit to a treatment plan built on assumptions.